Sale!

Cabergoline

£51.04

-28%
Cabergoline is a medicine used to lower high levels of a hormone called prolactin. It may help reduce symptoms such as abnormal breast milk production and may shrink certain hormone-related swellings in the pituitary gland. Cabergoline is usually taken by mouth in fixed doses, as advised by a healthcare professional. It can cause dizziness, headache, nausea or tiredness, especially when starting. If you feel unwell or notice mood changes, seek advice promptly.

Cabergoline: Patient-Friendly Guide (UK)

Cabergoline is a medicine used to treat conditions related to high levels of a hormone called prolactin, and in some cases to help manage symptoms caused by certain hormone-secreting growths. It belongs to a group of medicines known as dopamine agonists. When used correctly, cabergoline can be very effective, but it also requires careful monitoring because dosing, side effects, and safety precautions vary depending on the condition being treated.

This guide explains what cabergoline is, how it works, how it behaves in the body, typical uses, how to take it, and important safety and interaction considerations—tailored for people in the United Kingdom.


Basic product information

Category Details
Generic name Cabergoline
Medicine group Dopamine agonist (ergot-derived)
Common indications Raised prolactin; prolactin-secreting pituitary tumours
How it is taken Oral tablets
Typical dosing frequency Often once or twice weekly (depends on condition)
Important safety notes May affect heart valves at higher or long-term doses; monitor as advised

What cabergoline is used for

Cabergoline is used mainly to lower prolactin. Prolactin is a hormone produced by the pituitary gland (a part of the brain). High prolactin levels can cause symptoms such as changes in periods, infertility, milk discharge, and sexual function problems. In some people, prolactin rises because of a pituitary adenoma (a benign tumour that secretes prolactin).

In the UK, cabergoline is commonly prescribed for:

  • Prolactin-related conditions, including:
    • High prolactin levels (hyperprolactinaemia)
    • Prolactin-secreting pituitary tumours (prolactinoma)
  • Other dopamine-responsive hormone disorders (as decided by specialists based on individual clinical factors)

Who should be especially careful? People with a history of heart valve disease, those with symptoms like shortness of breath or chest discomfort, and those taking multiple medicines that affect blood pressure or dopamine systems should discuss their situation promptly with a clinician.


How cabergoline works (mechanism of action)

Cabergoline works by mimicking the effects of dopamine, a natural chemical in the brain. Dopamine normally restrains the release of prolactin from the pituitary gland.

Key points:

  • Dopamine receptor stimulation: Cabergoline activates dopamine receptors (especially D2 receptors).
  • Lowering prolactin: This reduces prolactin production and often helps shrink prolactin-secreting tumours.
  • Symptom relief: As prolactin levels fall, related symptoms may improve over weeks to months.

Pharmacokinetics: how the body handles cabergoline

Understanding how cabergoline is processed can help explain why it’s taken only a few times per week and why effects can last.

  • Absorption: After taking a dose by mouth, cabergoline is absorbed from the gastrointestinal tract.
  • Distribution: It distributes throughout the body and can reach target sites in the brain and pituitary.
  • Metabolism: Cabergoline is metabolised primarily in the liver.
  • Elimination: The drug and its metabolites are eliminated from the body over time.
  • Half-life and long-lasting effect: Cabergoline has a long duration of action, which is why typical regimens may be once or twice weekly.

Note: Individual responses can differ. The prescribing plan is based on your prolactin levels, symptom response, and any tumour-related considerations.


Indications and expected results

In people with elevated prolactin due to pituitary conditions, cabergoline can:

  • Reduce prolactin levels
  • Improve symptoms such as:
    • Irregular or absent periods
    • Infertility related to high prolactin
    • Galactorrhoea (milk discharge)
    • Sexual dysfunction
    • Headaches or visual disturbances if a tumour affects nearby structures (symptom response varies)
  • In some cases, help shrink prolactin-secreting pituitary tumours

Timeframe: Many people notice symptom improvement within the first few weeks, but prolactin and tumour effects may take longer—often weeks to months. Doses are commonly adjusted gradually to reach the lowest effective dose.


Timing: when to take cabergoline

Cabergoline is usually taken as a tablet by mouth on a regular schedule. Many regimens are:

  • Once weekly or twice weekly depending on the condition and your target prolactin level.
  • Where possible, take it on the same day(s) each week to keep dosing consistent.

How to set a routine:

  • Choose a day/time that you can reliably remember.
  • Use a pill organiser or smartphone reminder.
  • If you miss a dose, follow the advice given by your healthcare professional or the medicine’s leaflet. Because the frequency is weekly, the approach to missed doses can differ from daily medicines.

Food interactions

Cabergoline can be taken with or without food. However, some people find that taking it with food helps reduce stomach upset or nausea.

Practical tips:

  • If you experience nausea, consider taking the dose with a light meal.
  • Avoid large alcohol binges around your dosing day (see alcohol section below), as this may worsen dizziness or drowsiness in susceptible individuals.

Important: Follow the specific instructions supplied with your product and your clinician’s guidance.


Alcohol and medicine interactions

Cabergoline affects dopamine pathways and can sometimes cause side effects such as dizziness, sleepiness, or low blood pressure. Alcohol may intensify these effects.

Alcohol

  • It is generally advisable to limit alcohol while starting cabergoline.
  • Be cautious with alcohol because it can increase the risk of sedation and falls, particularly if you feel light-headed.

Other medicines that may interact

Interactions depend on your full medication list. Some relevant examples include:

  • Antipsychotic medicines (e.g., dopamine antagonists) may reduce cabergoline’s effect because they work in opposition on dopamine receptors.
  • Medications that lower blood pressure may increase the risk of dizziness or fainting, especially when initiating or increasing cabergoline.
  • Medicines that affect the brain’s dopamine system may increase the risk of side effects or alter effectiveness.
  • Macrolide antibiotics (some types) and certain other medicines may affect drug metabolism in ways that could change cabergoline levels—your clinician or pharmacist can advise based on your exact prescription.

Always inform healthcare professionals about:

  • All prescription medicines
  • Over-the-counter medicines
  • Herbal products and supplements
  • Any recreational substances

Dosing: how cabergoline is commonly taken

Dosing is individual. Cabergoline regimens typically start low to reduce side effects and to improve tolerability, then are adjusted based on response (such as prolactin levels and symptoms).

General dosing principles:

  • Start low and titrate upwards gradually if needed.
  • Use the lowest effective dose.
  • Doses are often scheduled once or twice weekly rather than daily.

Do not change your dose or dosing frequency without medical guidance. If you have concerns about side effects or effectiveness, speak to your healthcare professional promptly.

Missed dose note: Because the dosing schedule is frequently weekly, the best action after a missed dose depends on your plan. Your pharmacist or prescribing clinician can provide the safest instructions for your situation.


Safety profile and side effects

Like all medicines, cabergoline can cause side effects. Many are dose-related and may improve as your body adjusts. However, some potential risks require monitoring—especially with longer-term use and higher doses.

Common side effects

  • Nausea
  • Headache
  • Dizziness or light-headedness
  • Fatigue or sleepiness
  • Stomach discomfort
  • Low blood pressure, particularly when standing up quickly

Less common but important risks

  • Valvular heart disease risk (monitoring): Dopamine agonists, including cabergoline, have been linked to changes in heart valves, especially at higher cumulative exposure. Monitoring may be recommended based on dose and duration.
  • Impulse control or behavioural changes: Some people may experience unusual urges (for example gambling, increased libido, or compulsive behaviours). This risk should be discussed and monitored.
  • Sleep attacks: Rarely, people may experience sudden sleepiness. Avoid driving or operating machinery if you feel drowsy.
  • Psychiatric symptoms: Anxiety, mood changes, or hallucinations can occur in susceptible individuals.

Seek urgent medical advice if you experience

  • Fainting, severe dizziness, or chest pain
  • New or worsening breathlessness, swelling in legs, or unusual heartbeat symptoms
  • Severe allergic-type reactions (such as facial swelling or difficulty breathing)

Practical use tips (UK-friendly)

  • Take consistently: Keep to your scheduled day(s) each week.
  • Stand up slowly: If you feel light-headed, rise gradually from sitting/lying positions.
  • Track symptoms: Note changes in periods, headaches, vision symptoms, and any side effects.
  • Be cautious with driving: If you feel sleepy or dizzy, avoid driving and contact a healthcare professional.
  • Keep follow-up appointments: Monitoring can include prolactin blood tests and imaging or heart evaluation depending on your regimen.
  • Use a pill organiser: Weekly dosing can be easy to forget without structure.

Cardiovascular monitoring reminder: Your clinician may arrange a heart assessment (such as an echocardiogram) depending on the dose and duration. Don’t skip these appointments.


Alternative options

Depending on the underlying cause of high prolactin and your personal health history, clinicians may consider other treatment options. These may include:

  • Other dopamine agonists (for example, bromocriptine or other agents used for hyperprolactinaemia)
  • Surgery for selected pituitary tumour scenarios (usually considered by specialists)
  • Radiotherapy in particular cases where other options are unsuitable

Alternative choices depend on effectiveness, tolerability, tumour characteristics, and overall health, including heart health.


Market and legal context in the United Kingdom

In the UK, medicines are regulated and supplied in line with national medicines legislation and safety frameworks. Cabergoline is a well-established medicine within endocrine and specialist care, typically used under clinical review for appropriate conditions.

Availability: Cabergoline may be available through NHS services in appropriate clinical pathways and can also be supplied through private healthcare routes where permitted.

Safety governance: UK prescribers and pharmacists follow guidance designed to support safe use, including monitoring for known risks (such as valvular heart changes) and attention to drug interactions.

Patient responsibilities: Even when medication is obtained through an online pharmacy, it remains important to follow the dosing plan and monitoring requirements from your healthcare professional.


Recent guidance and monitoring considerations

Clinical practice in the UK continues to emphasize:

  • Individualised dosing to use the lowest effective dose
  • Monitoring prolactin levels to confirm biochemical control
  • Special attention to heart valve health for people on longer-term therapy or higher cumulative doses
  • Review of side effects such as sleepiness, dizziness, and impulse control changes

If you’re starting cabergoline or your dose is being increased, your healthcare team may advise closer follow-up during the adjustment period.


Delivery and availability (online pharmacy)

Availability can vary by strength and tablet presentation. On an online pharmacy website, products are typically listed with:

  • The active ingredient (cabergoline)
  • The strength (mg per tablet)
  • Tablet count per pack
  • Expected dispatch and delivery options across the UK

Delivery expectations: Many online pharmacies offer standard and express delivery options within the UK. Dispatch timelines depend on stock availability and verification checks.

Storage: Keep tablets in their original packaging, protected from excessive heat and moisture, and out of reach of children. If you have questions about storage for your specific product, check the leaflet inside the box.


FAQ: Cabergoline

1) What is cabergoline used for?

Cabergoline is mainly used to treat conditions caused by high prolactin, including prolactin-secreting pituitary tumours. It helps lower prolactin levels and can improve symptoms related to high prolactin.

2) How quickly does cabergoline work?

Some people notice symptom improvement within the first few weeks. However, prolactin levels and tumour-related effects may take weeks to months. Doses are often adjusted gradually based on your response.

3) Is cabergoline taken once a week?

It is commonly taken once weekly or twice weekly, depending on the condition, your prolactin levels, and tolerability. Always follow the schedule provided with your treatment plan.

4) Can I take cabergoline with food?

Cabergoline can usually be taken with or without food. If you experience nausea, taking it with a meal may help.

5) What alcohol interactions should I watch for?

Alcohol may worsen dizziness and sleepiness and may affect safety (for example, fall or driving risk). It’s usually advisable to limit alcohol, especially when starting or adjusting treatment.

6) What medicines should not be taken with cabergoline?

Some medicines may reduce cabergoline’s effectiveness or increase side effects. In particular, antipsychotic medicines and other drugs that affect dopamine pathways may interact. Always discuss your full medication list with a pharmacist or clinician.

7) Can cabergoline cause sleepiness?

Yes. Some people experience fatigue or sleepiness. If you feel drowsy, avoid driving or operating machinery and contact your healthcare professional for advice.

8) Does cabergoline affect the heart?

Cabergoline has been associated with heart valve changes in some patients, particularly with longer-term use and higher cumulative exposure. This is why clinicians may recommend heart monitoring such as echocardiography based on your dose and treatment duration.

9) What should I do if I miss a dose?

Because cabergoline is often taken weekly, the correct approach varies. Follow the instructions provided by your healthcare professional or the product information. If you’re unsure, contact a pharmacist for guidance.

10) Are there alternatives if cabergoline isn’t suitable?

Yes. Alternatives may include other dopamine agonists or, in selected cases, surgery or radiotherapy. The best option depends on the cause and how well you tolerate the medication.


Important final reminders

  • Cabergoline works best when taken regularly on your set schedule.
  • Monitor and report side effects, especially dizziness, sleepiness, unusual urges, or breathing/chest symptoms.
  • Follow any monitoring plan recommended by your healthcare professional, particularly for heart valve health.
  • Keep all appointments for blood tests and any investigations relevant to your condition.

If you have questions about whether cabergoline is appropriate for you, or you’re concerned about interactions with your current medicines, speak to a qualified healthcare professional or pharmacist. For online pharmacy orders, always check the product details (strength and pack size) before confirming your purchase.

Additional information

Dosage: No selection

0,25mg, 0,5mg

Package: No selection

8 pill, 12 pill, 16 pill, 20 pill, 32 pill